The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
NetCTLpan: pan-specific MHC class I pathway epitope predictions
Open accessAbstract
Reliable predictions of immunogenic peptides are essential in rational vaccine design and can minimize the experimental effort needed to identify epitopes. In this work, we describe a pan-specific major histocompatibility complex (MHC) class I epitope predictor, NetCTLpan. The method integrates predictions of proteasomal cleavage, transporter associated with antigen processing (TAP) transport efficiency, and MHC class I binding affinity into a MHC class I pathway likelihood score and is an improved and extended version of NetCTL. The NetCTLpan method performs predictions for all MHC class I molecules with known protein sequence and allows predictions for 8-, 9-, 10-, and 11-mer peptides. In order to meet the need for a low false positive rate, the method is optimized to achieve high specificity. The method was trained and validated on large datasets of experimentally identified MHC class I ligands and cytotoxic T lymphocyte (CTL) epitopes. It has been reported that MHC molecules are differentially dependent on TAP transport and proteasomal cleavage. Here, we did not find any consistent signs of such MHC dependencies, and the NetCTLpan method is implemented with fixed weights for proteasomal cleavage and TAP transport for all MHC molecules. The predictive performance of the NetCTLpan method was shown to outperform other state-of-the-art CTL epitope prediction methods. Our results further confirm the importance of using full-type human leukocyte antigen restriction information when identifying MHC class I epitopes. Using the NetCTLpan method, the experimental effort to identify 90% of new epitopes can be reduced by 15% and 40%, respectively, when compared to the NetMHCpan and NetCTL methods. The method and benchmark datasets are available at http://www.cbs.dtu.dk/services/NetCTLpan/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Universal Protein Resource (UniProt)
Bairoch, A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki070 · Cited by 3,774
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction
Larsen, M. V., Lundegaard, C., Lamberth, K., Buus, S., Lund, O., & Nielsen, M. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-424 · Cited by 982
Self-citationIMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES
Yewdell, J. W., & Bennink, J. R. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.51 · Cited by 944
HLA class I supertypes: a revised and updated classification
Sidney, J., Peters, B., Frahm, N., Brander, C., & Sette, A. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-1 · Cited by 775
NetMHCpan, a method for MHC class I binding prediction beyond humans
Hoof, I., Peters, B., Sidney, J., Pedersen, L. E., Sette, A., Lund, O., Buus, S., & Nielsen, M. (2009) · Immunogenetics · doi:10.1007/s00251-008-0341-z · Cited by 753
Self-citationSturniolo, T., Bono, E., Ding, J., Raddrizzani, L., Tuereci, O., Sahin, U., Braxenthaler, M., Gallazzi, F., Protti, M. P., Sinigaglia, F., et al. (1999) · Nature Biotechnology · doi:10.1038/9858 · Cited by 743
Nielsen, M., Lundegaard, C., Blicher, T., Lamberth, K., Harndahl, M., Justesen, S., Røder, G., Peters, B., Sette, A., Lund, O., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000796 · Cited by 719
Self-citationThe Universal Protein Resource (UniProt)
The UniProt Consortium (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl929 · Cited by 569
The Universal Protein Resource (UniProt) 2009
The UniProt Consortium (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn664 · Cited by 545
HLA-A2.1-Associated Peptides from a Mutant Cell Line: A Second Pathway of Antigen Presentation
Henderson, R. A., Michel, H., Sakaguchi, K., Shabanowitz, J., Appella, E., Hunt, D. F., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546329 · Cited by 520
Nielsen, M., Lundegaard, C., Lund, O., & Keşmir, C. (2005) · Immunogenetics · doi:10.1007/s00251-005-0781-7 · Cited by 491
Self-citationTenzer, S., Peters, B., Bulik, S., Schoor, O., Lemmel, C., Schatz, M. M., Kloetzel, P.-M., Rammensee, H.-G., Schild, H., & Holzhütter, H.-G. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4528-2 · Cited by 349
Identifying MHC Class I Epitopes by Predicting the TAP Transport Efficiency of Epitope Precursors
Peters, B., Bulik, S., Tampe, R., van Endert, P. M., & Holzhütter, H.-G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1741 · Cited by 339
Larsen, M. V., Lundegaard, C., Lamberth, K., Buus, S., Brunak, S., Lund, O., & Nielsen, M. (2005) · European Journal of Immunology · doi:10.1002/eji.200425811 · Cited by 313
Self-citationDefinition of supertypes for HLA molecules using clustering of specificity matrices
Lund, O., Nielsen, M., Kesmir, C., Petersen, A. G., R�der, G., Justesen, S., Lundegaard, C., Worning, P., Sylvester-Hvid, C., Lamberth, K., et al. (2004) · Immunogenetics · doi:10.1007/s00251-004-0647-4 · Cited by 292
Self-citationvan Endert, P. M., Tampé, R., Meyer, T. H., Tisch, R., Bach, J.-F., & McDevitt, H. O. (1994) · Immunity · doi:10.1016/1074-7613(94)90091-4 · Cited by 289
Craiu, A., Akopian, T., Goldberg, A., & Rock, K. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10850 · Cited by 264
Lundegaard, C., Lund, O., & Nielsen, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn128 · Cited by 250
Self-citationEpiJen: a server for multistep T cell epitope prediction
Doytchinova, I. A., Guan, P., & Flower, D. R. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-131 · Cited by 178
Distinct Proteolytic Processes Generate the C and N Termini of MHC Class I-Binding Peptides
Mo, X. Y., Cascio, P., Lemerise, K., Goldberg, A. L., & Rock, K. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5851 · Cited by 161
Koch, J., Guntrum, R., Heintke, S., Kyritsis, C., & Tampé, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312816200 · Cited by 161
Paz, P., Brouwenstijn, N., Perry, R., & Shastri, N. (1999) · Immunity · doi:10.1016/s1074-7613(00)80099-0 · Cited by 120
Intracellular transport of class I MHC molecules in antigen processing mutant cell lines.
Anderson, K. S., Alexander, J., Wei, M. L., & Cresswell, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3407 · Cited by 113
MAPPP: MHC class I antigenic peptide processing prediction.
Hakenberg, J., Nussbaum, A. K., Schild, H., et al. (2003) · PubMed · Cited by 111
CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening
Wang, M., Lamberth, K., Harndahl, M. N., Røder, G., Stryhn, A., Larsen, M. V., Nielsen, M., Lundegaard, C., Tang, S. T., Dziegiel, M. H., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.12.038 · Cited by 108
Self-citationRitz, U., & Seliger, B. (2001) · Molecular Medicine · doi:10.1007/bf03401948 · Cited by 99
Lévy, F., Burri, L., Morel, S., Peitrequin, A.-L., Lévy, N., Bachi, A., Hellman, U., den Eynde, B. J. V., & Servis, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4161 · Cited by 88
Elliott, T. J. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60741-5 · Cited by 84
Integrated modeling of the major events in the MHC class I antigen processing pathway
Dönnes, P., & Kohlbacher, O. (2005) · Protein Science · doi:10.1110/ps.051352405 · Cited by 79
Lund, O., Nielsen, M., Lundegaard, C., Keşmir, C., & Brunak, S. (2005) · The MIT Press eBooks · doi:10.7551/mitpress/3679.001.0001 · Cited by 74
Self-citationPérez, C. L., Larsen, M. V., Gustafsson, R. K. L., Norström, M. M., Atlas, A., Nixon, D. F., Nielsen, M., Lund, O., & Karlsson, A. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.5092 · Cited by 63
Self-citationAltuvia, Y., & Margalit, H. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3392 · Cited by 57
A Neural Network Model Approach to the Study of Human TAP Transporter
Brusić, V., Endert, P. V., Zeleznikow, J., Daniel, S., Hammer, J., & Petrovsky, N. (1999) · In Silico Biology · doi:10.3233/isb-00010 · Cited by 52
Rao, X., Costa, A. I. C. A. F., van Baarle, D., & Keşmir, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1526 · Cited by 49
Characterizing the N-Terminal Processing Motif of MHC Class I Ligands
Schatz, M., Peters, B., Akkad, N., Ullrich, N., Martinez, A. N., Carroll, O., Bulik, S., Rammensee, H., Endert, P. V., Holzhütter, H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3210 · Cited by 46
Re-evaluating the Generation of a “Proteasome-Independent” MHC Class I-Restricted CD8 T Cell Epitope
Wherry, E. J., Golovina, T. N., Morrison, S. E., Sinnathamby, G., McElhaugh, M. J., Shockey, D. C., & Eisenlohr, L. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2249 · Cited by 44
Juncker, A. S., Larsen, M. V., Weinhold, N., Nielsen, M., Brunak, S., & Lund, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007448 · Cited by 38
Self-citationT-Cell Epitope Prediction: Rescaling Can Mask Biological Variation between MHC Molecules
MacNamara, A., Kadolsky, U. D., Bangham, C. R. M., & Asquith, B. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000327 · Cited by 32
Tang, S. T., Wang, M., Lamberth, K., Harndahl, M. N., Dziegiel, M. H., Claësson, M. H., Buus, S., & Lund, O. (2008) · Archives of Virology · doi:10.1007/s00705-008-0194-7 · Cited by 19
Cited by
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Anagnostou, V., Smith, K. N., Forde, P. M., Niknafs, N., Bhattacharya, R., White, J., Zhang, T., Adleff, V., Phallen, J., Wali, N., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0828 · Cited by 896
Identification of neoantigens for individualized therapeutic cancer vaccines
Lang, F., Schrörs, B., Löwer, M., Türeci, Ö., & Sahin, U. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00387-y · Cited by 534
Immune epitope database analysis resource
Kim, Y., Ponomarenko, J., Zhu, Z., Tamang, D., Wang, P., Greenbaum, J., Lundegaard, C., Sette, A., Lund, O., Bourne, P. E., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks438 · Cited by 509
Self-citationThe Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
Fleri, W., Paul, S., Dhanda, S. K., Mahajan, S., Xu, X., Peters, B., & Sette, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00278 · Cited by 500
An overview of bioinformatics tools for epitope prediction: Implications on vaccine development
Soria-Guerra, R. E., Nieto-Gomez, R., Govea-Alonso, D. O., & Rosales-Mendoza, S. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.11.003 · Cited by 445
Metadata
- Authors
- Stranzl, T., Larsen, M. V., Lundegaard, C., & Nielsen, M.
- Venue
- Immunogenetics
- Published
- 2010-04-09
- Volume
- 62
- Issue
- 6
- Pages
- 357-368
- ISSN
- 0093-7711 (ISSN-L)
- 1432-1211
- OpenAlex
- W2142269152
- Cited by
- 392
- References
- 40
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.